BOTHELL, Wash. and VANCOUVER, British Columbia , Nov. 6, 2017 /CNW/ -- Achieve Life Sciences, Inc. (ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that the November 2 nd presentation given by Rick Stewart , Chairman and Chief Executive Officer, is now available for on-demand viewing at VirtualInvestorConferences.com.
Achieve provided an update and took real-time questions from investors and advisors on its clinical development plan for cytisine including recent phase 1 studies and near-term Phase 3 plans. The presentation will be available at https://tinyurl.com/1102postpr for 90 days and investors and advisors may download shareholder materials from the "virtual trade booth" for the next three weeks.
"It was a successful and enjoyable experience to present at Virtual Investor Conferences and have the opportunity to interact with and reach more investors in a real-time, interactive setting," said Rick Stewart .
About Achieve and Cytisine
Achieve is developing cytisine as a smoking cessation aid. Cytisine is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe for more than 20 years. It is estimated that over 20 million people have used cytisine to help combat nicotine addiction, including approximately 2,000 patients in Phase 3 clinical trials conducted in Europe and New Zealand . Achieve's focus is to address the global smoking health epidemic, which is currently the leading cause of preventable death and is responsible for nearly six million people losing their lives annually worldwide. Discussions have been held with the FDA and European regulatory agencies to determine the clinical and regulatory pathway towards making cytisine widely available.
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
Forward Looking Statements
This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Achieve may not actually achieve its plans or product development goals in a timely manner, if at all, or otherwise carry out its intentions or meet its expectations or projections disclosed in these forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including those risk factors set forth in Achieve's filings with the Securities and Exchange Commission from time to time, including the final Proxy Statement/Prospectus/Information Statement filed pursuant to Rule 424(b)(3) in connection with Achieve's recent merger, and Achieve's Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable law.
View original content with multimedia:http://www.prnewswire.com/news-releases/achieve-announces-availability-of-company-presentation-from-the-virtual-investor-conference-300549816.html
SOURCE Achieve Life Sciences, Inc.
View original content with multimedia: http://www.newswire.ca/en/releases/archive/November2017/06/c2125.html